The present study investigated the gastric emptying rate in Göttingen minipigs pre-and post-prandial and evaluated the effect of metoclopramide on the same parameter, using paracetamol as an absorption marker. The pharmacokinetic evaluation of the obtained plasma concentration data for paracetamol demonstrated that the fastest gastric emptying rate was observed in the animals that were allowed access to normal pig food. There was no significant difference in the stomach emptying rate observed between fasted and fed minipigs, when fed either with a FDA standard breakfast or a nutritional energy drink. Pre-dosing minipigs with metoclopramide (0.2 or 0.4 mg/kg) did not demonstrate any effect on gastric emptying in either the fasted or fed state. The data in the present study demonstrated a relatively prolonged gastric emptying rate in mini-pigs both in the fasted and fed state, hence when conducting pharmacokinetic studies using minipigs, this should be taken into account when planning the plasma sampling time points. Further, as no difference could be observed in gastric emptying rate as a function of food, the data also suggest that the Göttingen mini-pigs seems less suited to predict for food effect studies than other species.
Introduction
Reliable pre-clinical models for accurate evaluations of different formulations during drug development can be important to enable shorter development timelines. Here the pig model has shown good promise, given the physiological similarities to humans, where there is a general agreement that pigs could be a useful model for human oral absorption Kararli, 1995; Merchant et al., 2011; Sjögren et al., 2014; Walters et al., 2011) and thereby a potential valuable tool in drug formulation development.
Gastric emptying is a fundamental factor influencing drug absorption, given that any change in stomach emptying will influence the rate at which drug is presented for absorption in the small intestine. The transit time between the stomach and the small intestine is, therefore an important characteristic in the oral absorption process. Gastric emptying rates in various races of pigs have been reported to show high inter-individual and inter-study variability. Hossain et al. (1990) and Oberle and Das (1994) observed a long gastric emptying rate in landrace pigs, in the range of 6-24 h. In contrast to this, Davis et al. (2001) reported gastric emptying times after a light meal to be closer to 6 h in landrace pigs. While historically, landrace pigs were the most widely used species, in recent times, minipigs and in particular the Göttingen minipig have become common in pre-clinical studies (Forster et al., 2010) . However, relatively few studies investigating gastric emptying in minipigs have been reported in the literature. Christiansen et al. (2015) investigated the potential of a fed state model developed for dogs in Göttingen minipigs, but the reported data demonstrated that the protocol was not able to differentiate between drugs with positive or negative food effect. The study also reported relatively long gastric emptying rates in minipigs. Suenderhauf and co-workers (2014) assessed the pharmacokinetics of paracetamol in fasted Göttingen minipigs to assess gastric emptying times. The study found that gastric transit times in overnight fasted minipigs were longer than those observed in humans. The study also highlighted the need of further work to develop effective fasting protocols for minipigs, as it was observed that a 12 h fasting period was not sufficient to obtain an empty stomach in the animals, based on the residual stomach contents measured postmortem.
Interestingly, minipigs that received 00.2 mg/kg metoclopramide i.m. 2 h before necropsy had macroscopically empty stomachs, suggesting that this pre-treatment protocol with this pro-kinetic agent could be a feasible protocol to ensure consistent fasted state in minipigs. The amount and type of food ingested can have a significant influence on gastric emptying and resultant oral drug bioavailability (Houghton et al., 1990; McLaughlin et al., 1998) , and for this reason, it is a regulatory requirement to conduct fed and fasted state human clinical studies for all new oral medicines. Given the increasing need to streamline drug product development and avoid costly delays in clinical testing, pre-clinical in vivo models are an important tool to assess food dependent oral bioavailability -with a view to either predict likely food effects in humans or develop food independent formulation strategies. Currently, a pre-clinical food effect model is described in dogs (Lentz et al., 2007) , but given the similarities between humans and pigs gastrointestinal physiology, it is pertinent to consider the development of a protocol for food effect studies in the pig. The study by Christiansen et al. (2015) demonstrated that the protocol for dogs could not be transferred directly to minipigs due to the long gastric emptying rate observed relative to humans. However, the observations by Suenderhauf et al. (2014) involving pre-treatment with 0.2 mg/kg metoclopramide to ensure gastric emptying represents a potentially interesting approach to ensure to developing a protocol in minipigs.
Paracetamol is known to be poorly absorbed in the stomach, but rapidly absorbed upon entry into the small intestine, which makes it a good marker when examining gastric emptying rate (Clements et al., 1978; Heading et al., 1973) . The aim of the present study was to investigate the gastric emptying rate in Göttingen minipigs in the pre-and post-prandial state after administration of different food sources as well as examining the impact of pre-administration of metoclopramide on paracetamol absorption under varying prandial conditions.
Materials and methods

Materials
500 mg paracetamol (Panodil®) film-coated tablets were obtained from Glaxo Smithkline (Brentford, UK). Fresubin energy drink ® was from Fresenius Kabi (Bad Homburg, Germany). Paracetamol and metoclopramide was purchased from Sigma-Aldrich Co (St.Louis, MO, USA) and sodium chloride from Fluka Chemie AG (Buchs, Switzerland). Purified water was obtained from a Millipore Milli-Q Ultrapure Water purification system (Billeria, MA, USA). All other chemicals were of analytical grade.
In vivo study
The protocol used for the in vivo study was approved by the institutional animal ethics committee in accordance with Danish law regulating experiments on animals and in compliance with EC directive 2010/63/EU and the NIH guidelines on animal welfare. Female Göttingen minipigs were obtained from Ellegaard Göttingen Minipigs A/S (Dalmose, Denmark) weighing 9.1-11.3 kg at the start and 15.5-18.3 kg at the end of the study. Animals were acclimatised for 14 days before initiation of the study. During the acclimatisation period, animals were trained to eat both FDA standard breakfast (800-1000 kcal) and the Fresubin energy drink (375 kcal). The FDA standard breakfast consisted of two slices of bacon, two slices of buttered toast, two fried eggs, eight ounces of full milk, and four ounces of hash browns, which was homogenised and presented to the animals. Altromin 9023 (602 kcal; contains 25 fat kg ). was utilized as a normal pig food, the pigs were fed 120 g twice a day. The minipigs were examined weekly by a veterinarian and observed closely at the end of each experimental day. Before entering the experiment, minipigs were fasted for 18-20 h with free access to water. They were housed with straw as bedding and stabled individually from the fasting period until the last blood sample was taken. Minipigs were kept on a 12 h light and 12 h night cycle throughout the experiment.
The study design was a non-randomized one sequence design with a 7-day wash-out period between treatments. Minipigs (n = 6) were weighed on the day and orally dosed with 2 tablets of paracetamol (1000 mg). A total sample size of 6 animals was required to achieve significance for comparisons between groups, using a paired t-test to assess difference between at a significance level of p = 0.05. These calculations were performed on G Power (version 3.1.9.2 University Kiel, Germany) and were based on an effect size 1.5, α error probability 0.05, and with a power of 0.80.
The following treatment groups were conducted: In addition, the animals were administered paracetamol intravenously. The intravenous paracetamol formulation contained 24 mg paracetamol/mL, which was dissolved in purified water containing 0.7% (w/v) NaCl, and the pH was adjusted to 8.0. Each animal received 10 mL, i.e. a dose of 240 mg.
4 mg/mL metoclopramide solution for intramuscular injection was prepared in 0.9% sterile NaCl by magnetic stirring at ambient temperature and subsequent aseptic filtering through a sterile 0.22 μm filter into a sterile vial. The intramuscular dose was therefore 0.5 or 1 mL/ 10 kg, for the 2 and 4 mg/kg dose, respectively. Metoclopramide was injected intramuscularly 2 h before paracetamol dosing and the food or energy drink was presented to the animals 30 min prior to oral dosing of the paracetamol tablets. In all cases the animals finished their meals quickly.
Blood samples (3.0 mL) were obtained by individual vein puncture of the vena jugularis. Blood samples were collected at 5, 15, 30 min 1, 2, 4, and 7 h after drug administration. Blood samples were collected into ethylenediaminetetraacetic acid (EDTA) coated tubes and immediately centrifuged for 10 min at 4°C, 2765 g (Centrifuge Multifuge 1 S-R; Heraeus, Hanau, Germany). Plasma was harvested and stored at −80°C until analysis.
Bioanalysis
Plasma concentrations of paracetamol were measured by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) as previously described (Christiansen et al., 2015) . In short, calibration standards and quality control (QC) samples were prepared by spiking drug-free porcine plasma and an internal standard [deuterated paracetamol (Toronto Research Chemicals Inc., Toronto, Ontario, Canada), in 10% trichloroacetic acid] was added to 10 μL of the calibration standards. The inter-assay inaccuracy was within ± 15% for all concentrations.
The MS peak area correlated linearly with the plasma concentration of the paracetamol in the range of 10-2000 ng/mL. If plasma concentrations exceeded the linear range, appropriate dilution was performed.
Pharmacokinetic analysis
The pharmacokinetics of paracetamol in plasma of individual pigs was determined. After intravenous administration, the pharmacokinetic parameters for paracetamol were determined using compartmental pharmacokinetic analysis. Following oral administration of paracetamol, the area under the plasma concentration time curve (AUC), and mean residence time (MRT) were determined from non-compartmental analysis. Absolute bioavailability (F abs ) is defined as follows:
F was determined as the dose normalised peak areas ratio of the oral to intravenous plasma profiles as follows: 
The area under the curve during the 7 hours sampling period (0-7 h) was not consistently > 80% AUC total (calculated as AUC 0-7h plus the AUC of the extrapolated tail segment from 7 h-∞) across all treatment groups. As a result, absolute bioavailability was expressed as F abs 0−7h determined using the AUC ratios within the sampling period.
Parameters representative of the gastric emptying, equal to the absorption profile included; a) the maximum plasma concentration (C max ), b) the time corresponding to maximum plasma concentration (t max ), c) the mean absorption time (MAT), and d) the cumulated absorbed amount of paracetamol calculated by deconvolution.
MRT for a drug administered by a non-instantaneous input involves a mean absorption time (MAT), and can be defined as follows:
where MRT po and MRT iv represent the mean residence time of oral paracetamol and intravenous paracetamol. The MRT iv was based on the intravenous group and MRT po was determined from the six individual animals in each group, hence each individual animal served as its own control.
Deconvolution
Correlation between time functions, such as absorption and plasma concentrations, can mathematically be treated by system analysis (Langenbucher, 1982) . The plasma concentration profile obtained after oral administration can be treated as the response function R(t), i.e. the response observed when administering a compound. W(t) is the weighting function of the body system, as observed after intravenous or oral bolus administration. The correlation between the weighting and response function depends upon the input and can algebraically be described by the integral (Langenbucher, 1982) :
where R, I and W are the response, input and weighting functions, respectively. I(t) combines the release and absorption process and can be described as release time function. The integral of this form is known as the convolution integral, written as:
where * is the convolution operator. In the current study, R(t) and W(t) were known, i.e. I(t) representing the absorption process was sought, denoted deconvolution. Langenbucher (1982) previously described, the response function R(t), deconvolved with the weight function W(t) as:
A number of approaches exist to solve the deconvolution problem (Madden et al., 1996) , but in the present study numerical deconvolution, as described by Langenbucher (1982) , was used and approximated with the sum:
where T is the time interval, I(X k ) and W(X k ) the average input rate and weight between the times X k-1 and X k . The numerical deconvolution was based on the obtained plasma concentration data. The deconvolution profiles provide a dynamic picture of the absorption process, and were used to determine the time taken to absorb various fractions of paracetamol. The data were normalised across the different treatments and presented as percentage of total absorbed paracetamol fraction. Mean time points for 25%, 50% and 75% absorbed paracetamol were calculated from the deconvolution profiles.
Statistical analysis
The pharmacokinetic analysis was conducted using the PKPlus™ module in Gastroplus™ (ver. 9.0, Simulations Plus Inc., Lancaster, Ca.), and the deconvolution was conducted in Excel. Results are presented as means and their standard error mean ( ± S.E.M.). A nonparametric statistical test was used, the Kruskal Wallis rank test, with Dunn's multiple comparison rank sums to determine the significance of difference in t max , AUC, bioavailability and C max . All statistical analyses were performed using GraphPad Prism version 5, and 5% was considered significant.
Results and discussion
In the present study, the gastric emptying rate in Göttingen minipigs was investigated under a number of different prandial conditions, including investigation of the influence of pre-dosing of metoclopramide.
Intravenous administration
In order to assess the disposition kinetics of paracetamol in minipigs, a paracetamol solution containing 240 mg of paracetamol was administered intravenously (i.v.). The paracetamol plasma concentration time profile obtained after i.v. administration is shown in Fig. 1 . A two-compartmental model was found to adequately fit the data. The observed volume of distribution was 0.83 ± 0.12 L/kg, which was comparable to values reported for minipigs elsewhere (0.7 L/kg) (Suenderhauf et al., 2014) . In landrace pigs, a volume of distribution of 1.5 L/kg has been reported (Neirinckx et al., 2010) . The total clearance of paracetamol in this study was determined to be 0.5 ± 0.0 L/(h * kg), which was 50% lower compared to mean systemic clearance of paracetamol in landrace pigs of 0.9 L/(h * kg) (Neirinckx et al., 2010) . European Journal of Pharmaceutical Sciences 118 (2018) 183-190 3.2. Absorption of paracetamol pre-and post-prandial
Mean plasma concentration time profiles of paracetamol following the eight different dosing conditions are shown in Figs. 2 and 3 and the associated mean pharmacokinetic parameters are presented in Table 1 . Mean absorption time (MAT) is summarized in Fig. 4 , and deconvolution fractiles in Table 2 . In general, a lag phase was observed between oral administration of paracetamol and the onset of absorption.
Effect of food intake
Food intake leads to a slower gastric emptying rate, which generally leads to a longer t max and lower C max when drug is dosed post-rather than pre-prandially. This may also potentially affect the overall extent of drug absorbed (Christiansen et al., 2015) . Differences in t max or other pharmacokinetic parameters for paracetamol when dosed either in fasted or fed state would therefore reflect how the ingested meal delays gastric emptying, given paracetamol is rapidly absorbed once it enters the small intestine. The current study explored the use of t max , MAT, and deconvolution profiles to detect differences in the absorption profiles between the different treatment groups investigated, namely: (i) homogenised FDA breakfast, (ii) a nutritional energy drink, and (iii) normal pig food, 120 g, provided twice a day. Fig. 2A displays the plasma concentration profiles for the four groups: Fasted, FED Pig food , FED FDA breakfast , FED Energy drink . While there was a general trend towards a higher AUC in the fasted than in the fed state, there were no statistical differences in either AUC or C max for each treatment group. The time to reach peak concentrations (t max ) of Fasted, FED FDA breakfast and FED Energy drink groups was approximately 4 h (see Fig. 2B ), whereas for the group fed with pig food, t max was reached at 1.6 h.
The mean plasma concentration profile from the fasted minipigs, showed a second plasma peak, which on closer evaluation of the individual plasma profiles, was present in three of the six pigs in the group. For the animals pre-administered with metoclopramide this was only observed in one of the six animals. Appearance of double peaks after oral administration is not an uncommon phenomenon and has been described previously in the literature for other compounds (Charman et al., 1993; Lipka et al., 1995; Metsugi et al., 2008; Takamatsu et al., 2002; Langguth et al., 1994) , and has also been reported for paracetamol (Clements et al., 1978) . The exact reason for the double peak is unclear, but variable gastric emptying has previously been suggested as a cause for the double peaks with paracetamol (Metsugi et al., 2008) . The occurrence of a second plasma peak in paracetamol plasma profiles in the present study may therefore be related to variable gastric emptying in pigs.
Additionally, one animal in the fasted group had a plasma concentration profile where the absorption was incomplete within the 7 hours sampling period, and therefore a distinct elimination phase could not be determined from the terminal phase of the plasma profile. This may reflect that a truly fasted state was not achieved with a fasting period of 20 h, as suggested by Suenderhauf et al. (2014) . Comparing the fasted group with the group dosed with the nutritional energy drink ( Fig. 2A) , it was apparent that the plasma concentration profiles had similar shapes, but the fed state profile was shifted to the right with a 
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European Journal of Pharmaceutical Sciences 118 (2018) 183-190 lag time of 1 h. After 1 h, the absorption curve closely followed the fasted state curve. MAT has previously been used to estimate the absorption time (Ikegami et al., 2003; Mizuta et al., 1990 ) with a short MAT indicating fast absorption. The lowest MAT was observed for the minipigs fed with pig food (see Fig. 2C ). The animals receiving the FDA breakfast had a MAT similar to fasted minipigs, whereas the group administered with the Fresubin energy drink had a slightly longer MAT than the fasted group. The differences in MAT were not statistically significant between the groups.
A similar rank order between groups was observed in the deconvolution profile of paracetamol, with the slowest absorption observed for the animals receiving energy drink, followed by fasted, FED FDA breakfast and FED pig food (see Fig. 2D ). For the groups receiving pig food or the FDA breakfast, there was no significant difference between the deconvolution profiles, and these groups had slightly faster absorption profiles than the animals receiving Energy drink. The deconvolution analysis demonstrated that the profile of the animals receiving the Fresubin energy drink showed an initial delay of approximately 1 h, indicating a delayed absorption rate. The use of the energy drink as an energy source therefore led to a different absorption profile, relative to both the fasted and the fed stage induced with the FDA standard breakfast.
To compare the differences between the deconvolution profiles in more detail the exact time points for 25%, 50% and 75% absorbed paracetamol where calculated, see Table 2 . For minipigs fed with pig food, 50% of the drug was absorbed after 1.9 h, whereas for the fasted minipigs it took > 3 h to absorb 50% of the paracetamol dose. Similar to previous findings, this is again indicative of a faster gastric emptying rate in minipigs fed the normal pig feed. Possible reasons for this are unclear but may be related to animal habituation. Despite training of the animals with the different food sources, they still received normal pig food the majority of the time, hence, the animals may perceive the normal feed as less stressful or their digestive system may simply be better adjusted to normal pig food. This may be reflected in the faster gastric emptying rate in these animals.
In summary, the data presented here showed that the fasted group had a trend towards a higher extent of absorption when compared to the fed states, but all in all there was no clear and significant differences in paracetamol absorption between fasted and fed Göttingen minipigs. These findings are in accordance with previous studies (Christiansen et al., 2015) . A delayed gastric emptying in the fed state groups could be expected, as food has the characteristics to delay gastric emptying (Sjögren et al., 2014) . Lack of clear difference between the groups indicates that a 'true' fasted state could not be achieved within a fasting period of 18-20 h, as also previously described in the literature (Suenderhauf et al., 2014) . The observed lag times for fed state treatment were comparable and similar to human lag times; 0.6-1.4 h in various fed states (Hellmig et al., 2006) . Based on present knowledge the variable absorption rates and difficulties in obtaining a true fasted state in minipigs, suggest that the minipig may be less useful for food effect studies in pharmaceutical drug formulation development.
Effect of metoclopramide on gastric emptying
Drug absorption in the pre-and post-prandial states is an important parameter for new drug candidates and their associated formulations during the development process. Christiansen and co-workers (2015) reported relative slow gastric emptying in minipigs, which Suenderhauf et al. suggested may be overcome by pre-treatment with 0.2 mg/kg of metoclopramide. Metoclopramide is a prokinetic agent and accelerates gastric emptying in man (Behar and Ramsby, 1978) . A similar dose of 0.2 mg/kg metoclopramide was previously used in pigs to control gastric emptying (Gregory et al., 1995) . The current study utilized doses of 0.2 mg/kg and 0.4 mg/mg administered 2 h pre-dosing.
Influence of metoclopramide in the fasted state
Administration of 0.2 mg/kg metoclopramide led to a marginally higher t max and MAT (see Table 1 ), when compared to the fasted group, however, the difference were not statistically significant and hence gastric emptying was not considered to be influenced by the pretreatment. There was no clear difference in the plasma profiles with dosing at 0.4 mg·kg metoclopramide. While a trend towards a lower 229 ± 17,009 25,911 ± 10,808 17,214 ± 17,656 20,821 ± 19,355 14,504 ± 9519 25,488 ± 8824 15,109 ± 7619 14,641 ± 10,252 t max (h) 4.2 ± 1.6 5.8 ± 1.8 3.9 ± 3.4 1.6 ± 0.9 3.5 ± 2.7 5.6 ± 1.9 4.5 ± 1.2 2.8 ± 1.3 AUC 0→7 (ng⋅h/mL) 101, 018 ± 51,947 87,240 ± 32,829 44,875 ± 41,532 61,265 ± 56,062 42,605 ± 33,016 86,275 ± 19,041 54,766 ± 27,357 56,306 ± 43,684 F (%) 86. Fig. 4 . Mean absorption times of paracetamol after oral administration of 1000 mg, plots show median ± range (n = 4-6).
Table 2
Mean deconvolution time points (h) after oral administration of paracetamol 1000 mg (mean, n = 5-6). European Journal of Pharmaceutical Sciences 118 (2018) 183-190 AUC for the group dosed with the 0.4 mg/kg was evident, as shown in Table 1 , the difference in AUC was not statistically significant. For both plasma profiles, the paracetamol absorption was not fully completed at the end of the plasma sampling and no clear elimination phase was identified (Table 1 and Fig. 3A) . The deconvolution profiles and plasma concentration profiles of the fasted minipigs in comparison to the fasted pre-treated minipigs are presented in Fig. 3 . Overall there was no significant difference in the absorption of paracetamol between the groups (Fig. 3B, D, and F) . Therefore, the effect of pre-treatment of metoclopramide on lowering food content in the stomach of the minipigs observed by Suenderhauf et al. (2014) , did not translate into a faster gastric transit in our studies, as measured by paracetamol absorption. The reason for the lack of effect of metoclopramide on paracetamol absorption in fasted minipigs are unclear but may be related to the longer fasting period of 18-20 h applied in the present study, compared to 12 h in the study by Suendefhauf and co-workers, with the longer period of fasting allowing for sufficient time for complete gastric emptying.
Influence of metoclopramide in the fed state -FDA breakfast
To assess the influence of metoclopramide on fed state gastric motility, minipigs were pre-treated with 0.4 mg/kg of metoclopramide 1.5 h before oral administration of a FDA standard breakfast and or a total of 2 h before oral dosing of paracetamol. The pre-treatment of metoclopramide showed no significant effect on t max or MAT relative to the animals just receiving the FDA standard breakfast (see Table 1 ). A direct comparison of the plasma concentration profiles for the two groups are presented in Fig. 3C and the deconvolution profiles in Fig. 3D . The group pre-treated with metoclopramide showed a slower absorption and a lag time of 2 h, however, no significant differences was observed. These data therefore suggest that the pre-treatment with metoclopramide did not increase the gastric emptying rate in the animals when administered a FDA standard breakfast. The pre-treatment protocol investigated had no significant influence on the absorption profile of paracetamol in the fed state, and therefore does not provide an approach whereby food effects could be investigated in in fed-state minipigs.
3.3.3. Influence of metoclopramide in the fed state -nutritional energy drink For the animals fed the Fresubin energy drink no significant effect of pre-treatment of metoclopramide was observed on t max and MAT, relative to the fasted group. (Table 1 (Fig. 3A and E). Fig. 3F summarizes the mean deconvolution profile of the animals receiving 250 mL Fresubin energy drink 30 min before the oral administration of paracetamol and minipigs with or without pre-treatment of metoclopramide 2 h before paracetamol administration. The shape of the mean deconvolution profiles from the two groups was similar, but a trend towards an increased and faster absorption was observed for the metoclopramide pre-treated minipigs. The combination of metoclopramide pre-dosing and nutritional energy drink led to a deconvolution profile similar to the one obtained in the fasted animals, as shown in Fig. 3A and E. To reach a true fasted state in minipigs, the effect from the pre-treatment with metoclopramide was therefore insignificant both for the FDA breakfast and the energy drink. The use of metoclopramide, therefore, did not appear to influence the gastric emptying rate in either the fasted or any of the two investigated fed states. These data are not fully supportive of the observations presented by Suenderhauf and co-workers (2014) , which could reflect the differences in the methodology between the two studies, namely a fasting period of 18-20 h versus 12 h and estimating gastric emptying based on paracetamol absorption versus weighed post-mortem stomach contents.
Assuming that paracetamol is a relevant marker for gastric emptying in minipigs, the data in the present study confirmed that minipigs have a longer gastric emptying rate than man and that it was not affected by pre-treatment with 0.2-0.4 mg/kg metoclopramide. Food did not significantly influence the gastric emptying rate, neither the standard FDA breakfast nor an energy drink, and the most reliable protocol was obtained by allowing the minipigs to follow their normal feeding regime i.e. standard pig food. One limitation of this study was that the study was based on assessing food effect difference using paracetamol as a marker for gastric emptying, whereas it maybe possible that a drug with a more pronounced food effect in humans could be a more reliable marker. An additional limitation of the current study was that the most frequent blood sampling was conducted in the first hour after administration, which did not coincide the peak plasma concentrations observed for paracetamol in minipigs. For more reliable estimates of t max , frequent blood sampling near the C max are required. Therefore, future studies should take the delayed and variable absorption of paracetamol in minipigs into account with more frequent sampling around an estimated window of tmax of 2-6 h. Notwithstanding these limitations, it would appear that based on the current study, the impact of food on drug absorption in mini-pigs is highly variable and the investigated protocols are not supportive of fed versus fasted studies on oral dosage forms in this species.
Conclusion
The present study investigated gastric emptying rates in fasted and fed Göttingen minipigs and evaluated the effect of metoclopramide on the same parameter. The results indicated that a pre-treatment of metoclopramide did not regulate gastric emptying under any of the investigated conditions. In addition, the data demonstrated no significant difference in the stomach emptying rate between fasted and fed minipigs. None of the investigate protocols seemed able to induce a gastric emptying that would be extended when food was administered, as observed in humans. The minipig model appears to be less suited for exploring food effect interactions studies than other species.
